Skip to content

Factor X Deficiency C0015519

Published: July 22, 2026Updated: August 20, 2026

A rare genetic clotting disorder affecting the Stuart-Prower factor. Patients experience bleeding problems and require careful management.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Gastrointestinal bleeding

Generalized symptoms

(hematologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Hemarthrosis (joint bleeding)

(hematologic)

Epistaxis (nosebleeds)

(hematologic)

Soft tissue bleeding

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Fresh Frozen Plasma or Prothrombin Complex Concentrate

Replacement therapy provides Factor X to achieve hemostasis during bleeding or surgical episodes. PCCs offer concentrated dosing with reduced volume.

medication
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Pre-procedural Factor Replacement

Planned replacement therapy before surgical or dental procedures prevents intraoperative and postoperative bleeding complications.

procedure

Additional treatment options

Injury Prevention Strategies

Avoidance of contact sports, high-risk activities, and situations that increase trauma exposure reduces bleeding episodes.

lifestyle

Regular Bleeding Assessment

Scheduled clinical evaluations and laboratory testing to track bleeding frequency and response to treatment.

monitoring

Antifibrinolytic Agents

Aminocaproic acid or tranexamic acid may be used as adjunctive therapy for mucosal bleeding by stabilizing clots.

medication

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Factor X Deficiency C0015519?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Factor X Deficiency C0015519. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy